Insider Buy/Sell Details for the Biotechnology Industry — February 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (936)
Gemini Therapeutics, Inc. (GMTX)
Franchi Jean M. — Chief Financial Officer
Shares
353
Price
$69.06
Total Value
$24.38K
Shares Held After
70,990
% of Holdings
0.5%
Q32 Bio Inc. (QTTB)
Kalowski Lee — CFO and President
Shares
3,995
Price
$4.51
Total Value
$18.04K
Shares Held After
35,943
% of Holdings
10.0%
Q32 Bio Inc. (QTTB)
Morrison Jodie Pope — Director
Shares
9,896
Price
$4.51
Total Value
$44.67K
Shares Held After
89,104
% of Holdings
10.0%
Q32 Bio Inc. (QTTB)
Violette Shelia M. — Chief Scientific Officer
Shares
2,815
Price
$4.51
Total Value
$12.71K
Shares Held After
55,569
% of Holdings
4.8%
Climb Bio, Inc. (CLYM)
Thomas Stephen Basil — Director
Shares
33,687
Price
$7.00
Total Value
$235.96K
Shares Held After
170,970
% of Holdings
16.5%
LEXICON PHARMACEUTICALS, INC. (LXRX)
DEBBANE RAYMOND — Director
Shares
2,000
Price
$1.49
Total Value
$2.98K
Shares Held After
1,906,186
% of Holdings
0.1%
NewAmsterdam Pharma Co N.V. (NAMS)
Davidson Michael H. — Director
Shares
1,300
Price
$36.68
Total Value
$47.68K
Shares Held After
459,859
% of Holdings
0.3%
NewAmsterdam Pharma Co N.V. (NAMS)
Davidson Michael H. — Director
Shares
10,436
Price
$35.96
Total Value
$375.28K
Shares Held After
461,159
% of Holdings
2.2%
NewAmsterdam Pharma Co N.V. (NAMS)
Davidson Michael H. — Director
Shares
46,517
Price
$35.11
Total Value
$1.63M
Shares Held After
471,595
% of Holdings
9.0%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Sachdev Amit — EVP Chief Patient & Ext Af Off
Shares
1,846
Price
$486.35
Total Value
$897.80K
Shares Held After
55,570
% of Holdings
3.2%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Tatsis Ourania — EVP, Chief Reg. & Quality Off.
Shares
260
Price
$486.35
Total Value
$126.45K
Shares Held After
46,763
% of Holdings
0.6%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
McKechnie Duncan — EVP, Chief Commercial Officer
Shares
2,410
Price
$489.00
Total Value
$1.18M
Shares Held After
17,559
% of Holdings
12.1%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
McKechnie Duncan — EVP, Chief Commercial Officer
Shares
2,500
Price
$486.35
Total Value
$1.22M
Shares Held After
19,969
% of Holdings
11.1%
Krystal Biotech, Inc. (KRYS)
JANNEY DANIEL — Director
Shares
700
Price
$275.00
Total Value
$192.50K
Shares Held After
92,837
% of Holdings
0.7%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Ambrose Kristen — SVP & Chief Accounting Officer
Shares
223
Price
$486.35
Total Value
$108.46K
Shares Held After
6,981
% of Holdings
3.1%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Biller Jonathan — EVP and Chief Legal Officer
Shares
945
Price
$486.35
Total Value
$459.60K
Shares Held After
13,659
% of Holdings
6.5%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Atkinson Edward Morrow III — EVP, Chief Technical Ops. Off.
Shares
668
Price
$486.35
Total Value
$324.88K
Shares Held After
18,432
% of Holdings
3.5%
Arcellx, Inc. (ACLX)
Gilson Michelle — CHIEF FINANCIAL OFFICER
Shares
11,219
Price
$113.82
Total Value
$1.28M
Shares Held After
33,938
% of Holdings
24.8%
Kymera Therapeutics, Inc. (KYMR)
Mainolfi Nello — Director
Shares
8
Price
$93.49
Total Value
$747.92
Shares Held After
666,195
% of Holdings
0.0%
Kymera Therapeutics, Inc. (KYMR)
Mainolfi Nello — Director
Shares
1,501
Price
$92.81
Total Value
$139.31K
Shares Held After
666,203
% of Holdings
0.2%
Kymera Therapeutics, Inc. (KYMR)
Mainolfi Nello — Director
Shares
3,293
Price
$91.76
Total Value
$302.17K
Shares Held After
667,704
% of Holdings
0.5%
Kymera Therapeutics, Inc. (KYMR)
Mainolfi Nello — Director
Shares
5,434
Price
$90.39
Total Value
$491.18K
Shares Held After
670,997
% of Holdings
0.8%
Kymera Therapeutics, Inc. (KYMR)
Mainolfi Nello — Director
Shares
19,764
Price
$89.78
Total Value
$1.77M
Shares Held After
676,431
% of Holdings
2.8%
UNITED THERAPEUTICS Corp (UTHR)
CAUSEY CHRISTOPHER — Director
Shares
1,000
Price
$520.00
Total Value
$520.00K
Shares Held After
4,190
% of Holdings
19.3%
NewAmsterdam Pharma Co N.V. (NAMS)
Davidson Michael H. — Director
Shares
3,161
Price
$36.46
Total Value
$115.25K
Shares Held After
459,859
% of Holdings
0.7%
NewAmsterdam Pharma Co N.V. (NAMS)
Davidson Michael H. — Director
Shares
61,547
Price
$36.13
Total Value
$2.22M
Shares Held After
463,020
% of Holdings
11.7%
EXELIXIS, INC. (EXEL)
Aftab Dana — EVP, Research and Development
Shares
47,918
Price
$44.50
Total Value
$2.13M
Shares Held After
616,106
% of Holdings
7.2%
Krystal Biotech, Inc. (KRYS)
JANNEY DANIEL — Director
Shares
2,425
Price
$274.90
Total Value
$666.63K
Shares Held After
93,537
% of Holdings
2.5%
Krystal Biotech, Inc. (KRYS)
JANNEY DANIEL — Director
Shares
930
Price
$269.50
Total Value
$250.64K
Shares Held After
95,962
% of Holdings
1.0%
Krystal Biotech, Inc. (KRYS)
JANNEY DANIEL — Director
Shares
1,674
Price
$268.67
Total Value
$449.75K
Shares Held After
96,892
% of Holdings
1.7%
Krystal Biotech, Inc. (KRYS)
JANNEY DANIEL — Director
Shares
1,891
Price
$267.37
Total Value
$505.60K
Shares Held After
98,566
% of Holdings
1.9%
Krystal Biotech, Inc. (KRYS)
JANNEY DANIEL — Director
Shares
4,339
Price
$266.62
Total Value
$1.16M
Shares Held After
100,457
% of Holdings
4.1%
Krystal Biotech, Inc. (KRYS)
JANNEY DANIEL — Director
Shares
1,604
Price
$265.54
Total Value
$425.92K
Shares Held After
104,796
% of Holdings
1.5%
Krystal Biotech, Inc. (KRYS)
JANNEY DANIEL — Director
Shares
900
Price
$264.60
Total Value
$238.14K
Shares Held After
106,400
% of Holdings
0.8%
Krystal Biotech, Inc. (KRYS)
JANNEY DANIEL — Director
Shares
62
Price
$263.05
Total Value
$16.31K
Shares Held After
107,300
% of Holdings
0.1%
Krystal Biotech, Inc. (KRYS)
JANNEY DANIEL — Director
Shares
373
Price
$271.09
Total Value
$101.12K
Shares Held After
0
% of Holdings
100.0%
Krystal Biotech, Inc. (KRYS)
JANNEY DANIEL — Director
Shares
370
Price
$269.83
Total Value
$99.84K
Shares Held After
373
% of Holdings
49.8%
Krystal Biotech, Inc. (KRYS)
JANNEY DANIEL — Director
Shares
3,963
Price
$268.97
Total Value
$1.07M
Shares Held After
743
% of Holdings
84.2%
Krystal Biotech, Inc. (KRYS)
JANNEY DANIEL — Director
Shares
6,671
Price
$268.04
Total Value
$1.79M
Shares Held After
4,706
% of Holdings
58.6%
Krystal Biotech, Inc. (KRYS)
JANNEY DANIEL — Director
Shares
11,673
Price
$266.97
Total Value
$3.12M
Shares Held After
11,377
% of Holdings
50.6%
Krystal Biotech, Inc. (KRYS)
JANNEY DANIEL — Director
Shares
8,986
Price
$266.18
Total Value
$2.39M
Shares Held After
23,050
% of Holdings
28.0%
Krystal Biotech, Inc. (KRYS)
JANNEY DANIEL — Director
Shares
3,557
Price
$265.08
Total Value
$942.88K
Shares Held After
32,036
% of Holdings
10.0%
Krystal Biotech, Inc. (KRYS)
JANNEY DANIEL — Director
Shares
1,733
Price
$264.12
Total Value
$457.73K
Shares Held After
35,593
% of Holdings
4.6%
Krystal Biotech, Inc. (KRYS)
JANNEY DANIEL — Director
Shares
569
Price
$262.91
Total Value
$149.59K
Shares Held After
37,326
% of Holdings
1.5%
Voyager Therapeutics, Inc. (VYGR)
Carter Todd Alfred — Chief Scientific Officer
Shares
4,174
Price
$3.76
Total Value
$15.69K
Shares Held After
145,718
% of Holdings
2.8%
Voyager Therapeutics, Inc. (VYGR)
Swartz Robin — COO & CBO
Shares
6,458
Price
$3.77
Total Value
$24.35K
Shares Held After
199,738
% of Holdings
3.1%
Voyager Therapeutics, Inc. (VYGR)
Sandrock Alfred — Director
Shares
14,197
Price
$3.79
Total Value
$53.81K
Shares Held After
484,060
% of Holdings
2.8%
Voyager Therapeutics, Inc. (VYGR)
Jorgensen Nathan D. — Chief Financial Officer
Shares
4,668
Price
$3.77
Total Value
$17.60K
Shares Held After
151,416
% of Holdings
3.0%
CODEXIS, INC. (CDXS)
Lutz Stefan — Chief Scientific Officer
Shares
5,862
Price
$1.13
Total Value
$6.64K
Shares Held After
130,421
% of Holdings
4.3%
Cocrystal Pharma, Inc. (COCP)
FROST PHILLIP MD ET AL — Director
Shares
20,000
Price
$1.00
Total Value
$19.95K
Shares Held After
1,908,551
% of Holdings
1.0%
Showing 101–150 of 936 transactions (page 3 of 19)